Services on Demand
- Similars in SciELO
Print version ISSN 0101-2800
J. Bras. Nefrol. vol.34 no.3 São Paulo July/Sept. 2012
Precil Diego Miranda de Menezes NevesI; Arthur Alberto de Oliveira e OliveiraI; Marcela Cristina de Oliveira e OliveiraII; Juliana Reis MachadoIII; Marlene Antônia dos ReisIV; Helena Moisés MendonçaV; Luiz Antônio Pertili Rodrigues de ResendeVI; Vilmar de Paiva MarquesVII
IComplete Undergraduate Education (Physician)
IIMedical Residency in the Medical Clinic (Cardiology Resident)
IIIMSc (PhD Student)
IVPhD (Associate Professor of General Pathology)
VIMSc (Substitute Professor)
INTRODUCTION: The detection of the renal artery stenosis in hypertensive patients can be a signal of systemic arterial atherosclerosis.
AIMS: To identify and characterize clinical-epidemiologically the hypertensive patients with renal artery stenosis, evaluating factors of cardiovascular risk and presence of symptomatic multiarterial atherosclerotic.
METHOD: Were selected the hypertensive patients who were assisted at the Nephrological Clinic of Universidade Federal do Triângulo Mineiro (UFTM) between 2000-2010, with diagnosis of renal artery stenosis of atherosclerotic etiology. Epidemiological data were evaluated (gender, age, ethnicity), factors of cardiovascular risk (diabetes, hypercholesterolemia, hypertriglyceridemia, tabagism, metabolic syndrome), information on hypertension (time of diagnosis, family report, number of used medicines), previous cardiovascular events (acute myocardial infarctation, ischemic stroke, peripheral arterial disease). Blood pressure levels, global cardiovascular risk and Score Framingham were stratified.
RESULTS: Casuistry of 30 patients, feminine majority (73.3%), average of 66 year-old age, 86.67% white, medium time of hypertension of 19.94 years, 89.92 without family report, 13.8 with diabetes, 65.51% smoking, 17.25% hypertriglyredemia, 62.06% with hypercholesterolemia and 66.7% with metabolic syndrome. Average number of medicines in use: 3.26. Dominant right-sided renal artery stenosis separately (46.7%) and in proximal third (56.7%). High creatinine levels in 40% of the patients. As for the hypertension phase, majority phase 2 (47%) and 73.3% with high global cardiovascular risk. Average Framingham Score of 13%. 66.7% presented atherosclerotic disease in another place, being infarctation the main one (53.3%).
CONCLUSION: The most common correlation was with acute myocardial infarctation, what implicates in the search of the coronary compromising to the diagnosis of renal artery stenosis in hypertensive patients to try avoid future damages to the patient.
Keywords: atherosclerosis, cardiovascular diseases, hypertension.
Systemic hypertension (SH) is a highly prevalent chronic disease, and its complications are of great impact to morbidity and mortality in the Brazilian and world populations.1
According to its etiology, SH can be classified in 2 subtypes: (1) primary/essential, which represents approximately 95% of SH cases and does not have a defined etiology, with an important genetic and environmental component; or (2) secondary, which corresponds to approximately 5% of cases and presents a defined etiology, given that some of these SH patients can be cured by treating the primary disease.1,2
Among the causes of secondary SH, parenchymal renal disease is the most frequent, followed by renovascular hypertension (RVHT), which is the most potentially curable cause of SH.2 The 2 main causes of renal artery stenosis that lead to RVHT are atherosclerosis, which is responsible for 90% of cases, and fibromuscular dysplasia, corresponding to less than 10% of cases.3,4
Atherosclerotic disease has many causes and can affect any portion of the arterial bed; however, macrovascular impairment occurs most frequently in the coronary, renal, carotid, and iliac-femoral arteries.5,6 Risk factors for its development, such as hypertension, advanced age, diabetes mellitus, and dyslipidemia, are the same for these various sites, and the presence of atherosclerosis in several sites is not an uncommon finding.4,6 According to some studies, the link between RVHT of atherosclerotic origin and multiartery atherosclerotic disease is common; however, only 1 concurrent arterial bed has been assessed in each study.4-8
Based on these data, the objectives of the present research were as follows: (1) identify and characterize, clinically and epidemiologically, hypertensive patients who had renal artery stenosis of atherosclerotic origin and were treated at the outpatient nephrology clinic of the Clinic Hospital of the Federal University of the Triângulo Mineiro; (2) stratify patients in relation to the stage of hypertension, risk factors for cardiovascular disease, individual global cardiovascular risk, Framingham score, and presence of metabolic syndrome; and (3) verify the presence of atherosclerotic cardiovascular events in this population, demonstrating the concomitance of renal artery stenosis of atherosclerotic origin and multiartery atherosclerotic disease in potentially affected areas (coronary, carotid, and peripheral artery circulation).
This study was a cross-sectional descriptive study. Patients were selected by analyzing the database of the patients treated at the outpatient clinic of Nephrology at the Federal University of the Triângulo Mineiro, between 2000 and 2010. These patients had been diagnosed with hypertension and renal artery stenosis of atherosclerotic etiology.
Clinical and epidemiological characterization
The assessments were conducted based on the following parameters: epidemiological data (gender, age, and ethnicity), information regarding hypertension (diagnosis time, family history, and the number of medicines used), laboratory results (total cholesterol, low-density lipoprotein [LDL], high-density lipoprotein [HDL], triglyceride, and creatinine levels), and risk factors for cardiovascular disease according to the VI Brazilian Guidelines of Hypertension9 (age > 55 years for men and > 65 years for women, smoking, dyslipidemia: triglyceride level > 150 mg/dL, LDL cholesterol level > 100 mg/dL, HDL level < 40 mg/dL, diabetes mellitus, premature family history of cardiovascular disease: < 55 years for men and < 65 years for women).
Diagnosis of hypertension with renal artery stenosis and assessment of renal function
The diagnosis of hypertension with renal artery stenosis was considered by observing the presence of hypertension characterized as systolic blood pressure (SBP) > 140 mmHg or diastolic blood pressure (DBP) > 90 mmHg,9 linked to luminal stenosis in > 70% of the renal artery. This analysis was conducted at our center by using color Doppler ultrasound or arteriography, confirming atherosclerotic etiology on the basis of the characteristics of stenosis.10
Renal function was assessed by measuring serum creatinine levels, and values > 1.3 mg/dL for males and > 1.2 mg/dL for females were considered abnormal. After obtaining data for the patients' weight (kg), gender, age (years), and serum creatinine levels (mg/dL), the estimated glomerular filtration rate (mL/min) was calculated by the Cockcroft-Gault formula11. The patients were then stratified with regard to the degree of chronic renal insufficiency, according to their glomerular filtration rates: 0, > 90 (risk groups for chronic renal disease, but without renal lesion); 1, >90 (renal lesion with normal renal function); 2, 60-89 (mild renal insufficiency); 3, 30-59 (moderate renal insufficiency); 4, 15-29 (severe renal insufficiency); and 5, < 15 (terminal or renal insufficiency requiring dialysis).12
Pressure level stratification, global cardiovascular risk, assessment of the criteria for metabolic syndrome, and Framingham score
After obtaining the casual SBP and DBP measurements at the clinic, the patients were stratified according to BP levels into stage I (SBP, 140-159 mmHg and/or DBP, 90-99 mmHg), stage II (SBP, 160-179 mmHg and/or DBP, 100-109 mmHg), or stage III (SBP > 180 mmHg or DBP > 110 mmHg), according to the VI Brazilian Guidelines of Hypertension.9 After obtaining the BP stratification by stage and the analysis of the cardiovascular disease risk factors, the overall cardiovascular risk of the patients was also stratified in accordance with the aforementioned guidelines.
Metabolic syndrome was diagnosed in accordance with the recommendations of the I Brazilian Guideline for the Diagnosis and Treatment of Metabolic Syndrome,13 corresponding to the combination of 3 of the following factors: abdominal obesity confirmed by waist circumference > 102 cm for men and > 88 cm for women, serum triglyceride level > 150 mg/dL, HDL cholesterol level < 40 mg/dL for men and < 50 mg/dL for women, SBP > 130 mmHg or DBP > 85 mmHg, and fasting blood glucose level > 110 mg/dL.
The Framingham score calculation14 was applied to subjects who did not show prior history of coronary disease. The patients were assessed according to the following variables: gender, age, total cholesterol and HDL cholesterol levels, BP value, presence of diabetes, and smoking status. Each of these items received a specific score. The total number of points obtained was transformed into risk percentages for the occurrence of a severe cardiovascular event in the next 10 years by using estimates. Participants were then stratified into 3 categories according to the level of risk mentioned above: low risk (< 10%), intermediate risk (between 10% and 20%), and high risk (> 20%).
Multiartery atherosclerotic disease analysis
Multiartery atherosclerotic disease was diagnosed by analyzing patient records, which showed their clinical history; this analysis helped identify previous and current symptomatic cardiovascular diseases (acute myocardial infarction [AMI], ischemic encephalic vascular accident [iEVA], and peripheral artery disease [PAD]).
For the statistical analysis, an electronic spreadsheet that contained the collected information was created. The data were analyzed and the results have been shown descriptively as percentage values.
This research was approved by the Research Ethics Committee of the Federal University of the Triângulo Mineiro under protocol number 1594.
At the Outpatient Nephrology Clinic of the Federal University of the Triângulo Mineiro, 33 patients underwent follow-up and had a diagnosis of hypertension with renal artery stenosis. Among these patients, 30 (90.9%) cases of hypertension were of atherosclerotic etiology, 2 (6%) were due to muscular fibrodysplasia, and 1 (3.1%) was due to polyarteritis nodosa.
The patient gender distribution was as follows: women, 73.3%; and men, 26.7%. The average patient age was 66.06 years (± 12.25 years); 86.67% of the patients were white and 13.33% were non-white. The average diagnosis time for hypertension was 19.94 years (± 5.32 years), and 89.28% of patients did not have a family history of SH. Most patients did not have diabetes mellitus (86.20%), 65.51% were smokers, 17.25% had hypertriglyceridemia, and 62.06% had hypercholesterolemia. The average number of medicines used was 3.26 (± 1.2).
Approximately 46.7% of the patients presented with renal artery stenosis only in the right renal artery, 20% had lesions only in the left renal artery, and 33.3% presented with bilateral lesions. The renal artery stenosis was located in the proximal third in 56.7% of the patients, and 43.3% had stenosis in the ostium. Approximately 40% of the patients showed high levels of serum creatinine, and 16.67% of the patients already showed chronic renal insufficiency under conservative treatment.
The distribution of patients with regard to the degree of arterial hypertension has been shown in Figure 1, and the distribution with regard to individual overall cardiovascular risk is shown in Figure 2. The Framingham Score of patients who did not have symptoms of coronary artery disease and who had never experienced a previous episode of AMI was 13% (± 2%), that is, a 13% chance of developing coronary artery disease and infarction in 10 years, indicating medium risk. Approximately 66.67% of the patients met the criteria for metabolic syndrome.
By studying symptomatic atherosclerotic arterial diseases in coexistence with hypertension and renal artery stenosis, we found that these diseases were present in 66% of the patients. AMI was the most common condition (53.3% of the cases), followed by iEVA (30% of the cases) and PAD (16.67% of the cases). There was coexistence of AMI and EVA in 30% of the cases, and AMI, iEVA, and PAD in 6.67% of the cases (Table 1).
Hypertension caused by renal artery stenosis results in an increase of BP due to renal ischemia caused by partial or total obstruction of 1 or both renal arteries.15,16 Chronic ischemia may result in renal function disturbances, in addition to lack of BP control, and may lead to salt and water retention disorders as well as renal endocrine function disorders.6 It is critical to differentiate renovascular hypertension from renovascular disease, in which stenosis of the renal artery is also present. However, these lesions doe not cause hypertension; therefore, if treated, it will not benefit the patient.16
In contrast to the findings reported in the literature in which males are most affected by hypertension with renal artery stenosis of atherosclerotic origin, representing up to 2/3 of cases,15 in our study there was a higher prevalence in females. This finding could be explained by the fact that the patients in our study were predominantly elderly, and this stage of life is marked by an increase in cardiovascular risk in women due to the effects of decreased estrogen.17 Moreover, women tend to seek medical services more frequently compared to men.18
According to the literature, hypertension with renal artery stenosis of atherosclerotic etiology is more common in elderly patients,5,6,16 which was also observed in our sample, as the average age of the patients was 66.06 years. With an increase in the population's life expectancy, this disease tends to be ever more prevalent.5 A plausible explanation for the increase in hypertension with renal artery stenosis of atherosclerotic origin due to aging is that senility is associated an increase in the prevalence of comorbidities such as hypertension, diabetes mellitus, and dyslipidemia, which are factors that facilitate the atherogenic process.6,16 When the etiology of hypertension with renal artery stenosis is analyzed, it can be observed that atherosclerosis is responsible for approximately 90% of cases,3,4,19,20 a percentage corroborated by our case series, in which 90.9% of the patients presented this etiology for renal artery stenosis. Overall, we observed that the stenosis was located in the ostium or proximal third of the renal artery and was more prevalent in the latter, which is also compatible with the literature.16,19,20
The habit of smoking alone, found in a large portion of the patients, is a significant risk factor for cardiovascular diseases, as it causes damage to the endothelial function and increased arterial rigidity and inflammation, and displaces the equilibrium between anti-thrombotic and thrombotic factors, thus favoring and accelerating the atherothrombotic process.21,22 Consequently, the habit of smoking in previously hypertensive patients favors the development of malignant and renovascular hypertension, in the case of atherosclerotic etiology, by promoting accelerated atherosclerosis.21
In hypertension with renal artery stenosis, the control of BP levels is difficult,15,23 which is evidenced by the fact that, even with an average number of medications of 3.26, the patients maintained high BP levels mostly at stage II of hypertension (according to the VI Brazilian Guidelines of Hypertension9).
Along with increased tension levels, these patients have other cardiovascular risk factors such as hypercholesterolemia, hypertriglyceridemia, and smoking that, when combined, indicate an individual cardiovascular risk that is high or very high in most cases.3,4 This finding can also be observed by the fact that 2/3 of the patients already met the criteria for metabolic syndrome, which reflects the presence of multiple metabolic risk factors for cardiovascular disease. Contrary to the relationship between diabetes mellitus type II and renal artery stenosis reported in the literature,5,6,8,24 our patients were mostly nondiabetics.
The patients in our case series showed an average SH diagnosis time of approximately 2 decades. Furthermore, the vast majority did not show family history of SH. The low incidence of hypertension with renal artery stenosis in patients with uncomplicated SH makes it cost ineffective to screen all hypertensive patients. Thus, clinical characteristics such as the following should cause a clinician to suspect that renal artery stenosis is the cause of the patient's hypertension: SH before the age of 30 or after the age of 50; abrupt installation; symptoms or signs of atherosclerotic disease; negative family history; smoking; renal dysfunction after the use of angiotensin-converting enzyme inhibitors; recurring pulmonary edema; white race; resistance or discontinuation of therapy with diuretics and antiadrenergics; accelerated, malignant, or refractory SH; changes during physical examination such as abdominal murmurs; history of occlusive vascular disease (coronary, cerebral, peripheral); advanced fundoscopic changes; or even changes in laboratory data such as hypokalemia, proteinuria, and increased serum levels of rennin or unilateral small kidney seen on ultrasound.1,2,23 Therefore, clinicians should continue their investigation to confirm the potential etiological cause.
Corroborating the observation that hypertension in patients with renal artery stenosis is usually difficult to control and that atherosclerotic disease is a cardiovascular risk factor, it is justified that the majority of the patients in our study were in stages II and III of hypertension, used a large number of medicines without adequately controlled BP levels, and had a high or very high overall cardiovascular risk associated with metabolic syndrome and Framingham scores ranging from moderate to high risk.2,15,23,25
In addition to hypertension, renal artery stenosis (particularly of atherosclerotic etiology) may cause renal insufficiency, especially when the stenosis is bilateral, by means of chronic ischemic nephropathy.6,26 This complication was also observed in our study, as some of the patients were already undergoing conservative treatment for chronic renal disease and others already presented changes in creatinine serum levels, indicating a possible unfavorable alteration in the renal function. It is estimated that approximately 12-16% of the patients with terminal chronic renal insufficiency have renal artery stenosis as the cause of their renal lesion, which causes ischemic nephropathy, especially when the stenosis is bilateral.27-29
Atherosclerotic arterial disease is a systemic disease. Finding the focus of atherosclerosis in an arterial bed indicates great predictive power of finding another focus in a concurrent location. According to the literature, the link between hypertension with renal artery stenosis of atherosclerotic origin and other atheromatous macrovascular diseases is common.30 In most patients, hypertension with renal artery stenosis develops as part of systemic atherosclerotic disease and is accompanied by this condition in other vascular beds, particularly in the coronary, carotid, aortoiliac, and iliofemoral circulation.6
While reviewing the literature to develop this work, we noticed the presence of only a few articles listing the concomitance of multiartery atherosclerotic disease, in its various forms, in the same population of patients with hypertension and renal artery stenosis. Additionally, the vast majority of the studies sought to identify the incidence of renal artery stenosis in the presence of some other prior atherosclerotic disease and did not make use of the presence of renal artery stenosis to search for other more common diseases, which was the objective of this study.
Kalra et al.30 verified in their observational study that 17.5% of the patients with hypertension and renal artery stenosis had already experienced an iEVA. In a series of patient autopsies, whose cause of death was an iEVA, Kuroda et al.31 noted the concomitant presence of renal artery stenosis in 10.4% of the cases. Alcázar et al.32 found this percentage to be 27.3%, and Hans et al.33 noted the concomitant presence of this condition in 7.2% of the patients. In our case study, we found a higher percentage than those reported (30% of patients), which could be explained by the older age of the patients in our sample.
In relation to peripheral artery disease, the concomitance with renal artery stenosis was observed with percentages between 25.8% and 44.9%.31,34-36 In our study, we obtained a percentage of 16.7%, which could be explained by the fact that peripheral artery disease is more common in males,37 and our case series included a majority of females.
In our study, we observed that AMI was the most common atherosclerotic disease in hypertensive patients with renal artery stenosis. Previous studies have shown that the prevalence of these comorbid conditions ranges from 11% to 30% (Jokhi et al.38: 30%, Kalra et al.30: 30.3%, Weber-Mizel et al.39: 18%, Handing et al.40: 11%, and Jean et al.41: 11%). The numbers in our case study (concomitance in 53.3% of the patients) was much higher than those observed in the literature, which could be explained by the high average age of the population in the study that in turn is accompanied by a higher prevalence of cardiovascular risk factors.2,15,23,25 Additionally, besides being the most commonly associated atherosclerotic disease, AMI is the main cause of death in hypertensive patients with renal artery stenosis of atherosclerotic etiology.31 It must also be emphasized that the patients who develop AMI may evolve to show symptoms of low chronic cardiac output, leading to exacerbation of the renal hypoperfusion syndrome, which is already in existence as a result of the hypertension due to renal artery stenosis.42,43
The mortality of hypertensive patients with renal artery stenosis of atherosclerotic origin is very high because the patients are generally elderly and because of the concomitance of the extra renal macrovascular comorbidities, particularly cardiac diseases. Furthermore, previous studies have shown that this condition alone is a major predicting factor for mortality when related to other cardiovascular diseases, especially when the stenosis is bilateral.25,30,44
Attention should be drawn to the importance of obtaining knowledge of the actual scenario in Brazil with regard to the association between hypertension with renal artery stenosis of atherosclerotic origin and other atherosclerotic diseases. The initial characterization of this population of hypertensive patients with renal artery stenosis was the first step to creating a specific outpatient clinic for this type of hypertension in our center, which will work by establishing a partnership between the Nephrology, Vascular Surgery, and Hypertension League subject areas.
Hypertension with renal artery stenosis of atherosclerotic origin in the study population was more common in elderly, white, and female patients, and was linked to various cardiovascular risk factors, including metabolic syndrome, with most patients having stage II/III hypertension, increased overall cardiovascular risk, and a Framingham score indicating medium risk. The most commonly associated atherosclerotic disease was AMI. These findings demonstrate that individuals with established atherosclerotic disease are at high cardiovascular risk and that all of their risk factors should be treated aggressively so that further damage can be avoided.
1. Corrêa TD, Namura JJ, Pontes-Silva CA, Castro MG, Meneghini A, Ferreira C. Hipertensão arterial sistêmica: atualidades sobre sua epidemiologia, diagnóstico e tratamento. Arq Med ABC 2005;31:91-101. [ Links ]
2. Praxedes JN. Hipertensão renovascular: epidemiologia e diagnóstico. Rev Bras Hipertens 2002;9:148-53. [ Links ]
3. Tumelero RT, Duda NT, Tognon AP, Thiesen M. Prevalência de Estenose das Artérias Renais em 1.656 pacientes que realizaram cateterismo cardíaco. Arq Bras Cardiol 2006;87:248-53. [ Links ]
4. Macêdo TA, Bortolotto LA. Associação de estenose de artéria renal e doença coronária em pacientes com hipertensão e aterosclerose. Rev Bras Hipertens 2009;16:190-1. [ Links ]
5. Canzanello VJ, Garovic VD. Renal Vascular Disease: A Vexing Challenge for the Clinician. Prog Cardiovasc Dis 2009;52:181-3. [ Links ]
6. Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis 2009;52:184-95. [ Links ]
7. Hegarty J, Wright JR, Kalra PR, Kalra PA. The heart in renovascular disease --an association demanding further investigation. Int J Cardiol 2006;111:339-42. [ Links ]
8. Davis RP, Pearce JD, Craven TE, Moore PS, Edwards MS, Godshall CJ, et al. Atherosclerotic renovascular disease among hypertensive adults. J Vasc Surg 2009;50:564-70. [ Links ]
9. VI Diretrizes Brasileiras de Hipertensão Arterial. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão e Sociedade Brasileira de Nefrologia; 2010. [ Links ]
10. Engelhorn CA, Engelhorn AL, Pullig R. O papel da ultrassonografia vascular com doppler colorido na avaliação da hipertensão renovascular: acurácia da técnica direta de avaliação das artérias renais. Arq Bras Cardiol 2004;82:473-6. [ Links ]
11. Madder RD, Hickman L, Crimmins GM, Puri M, Marinescu V, McCullough PA, et al. Validity of estimated glomerular filtration rates for assessment of baseline and serial renal function in patients with atherosclerotic renal artery stenosis: implications for clinical trials of renal revascularization. Circ Cardiovasc Interv 2011;4:219-25. [ Links ]
12. Romão-Junior JE. Doença Renal Crônica: Definição, Epidemiologia e Classificação. J Bras Nefrol 2004;26:1-3. [ Links ]
13. I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol 2005;84. [ Links ]
14. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. [ Links ]
15. Borelli FAO, Pimenta E. Hipertensão secundária - renovascular: diagnóstico e tratamento. Rev Soc Cardiol Estado de São Paulo 2008;18:135-40. [ Links ]
16. Elliott WJ. Secondary hypertension: renovascular hypertension. In: Black H, Elliott WG (eds). Hypertension: a Companion to Braunwald's Heart Disease. Philadelphia: Saunders Elsevier; 2007. p.93-105. [ Links ]
17. Woodard GA, Brooks MM, Barinas-Mitchell E, Mackey RH, Matthews KA, Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011;18:376-84. [ Links ]
18. Gomes R, Nascimento EF, Araújo FC. Por que os homens buscam menos os serviços de saúde do que as mulheres? As explicações de homens com baixa escolaridade e homens com ensino superior. Cad Saúde Pública 2007;23:565-74. [ Links ]
19. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431-42. [ Links ]
20. White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 2006;113:1464-73. [ Links ]
21. Virdis A, Giannarelli C, Neves MF, Taddei S, Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des 2010;16:2518-25. [ Links ]
22. Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens 2007;20:637-41. [ Links ]
23. Carvalho JGR. Hipertensão arterial secundária. Medicina (Ribeirão Preto)1996;29:220-31. [ Links ]
24. Chung W, Kim S. Atherosclerotic renovascular hypertension: lessons from recent clinical studies. Electrolyte Blood Press 2010;8:87-91. [ Links ]
25. Mafra F, Oliveira H. Avaliação do risco cardiovascular - metodologias e suas implicações na prática clínica. Rev Port Clin Geral 2008;24:391-400. [ Links ]
26. Adel SM, Syeidian SM, Najafi M, Nourizadeh M. Clinical efficacy of percutaneous renal revascularization with stent placement in hypertension among patients with atherosclerotic renovascular diseases. J Cardiovasc Dis Res 2011;2:36-43. [ Links ]
27. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis 1994;24:622-9. [ Links ]
28. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renal vascular disease. Am J Kidney Dis 1998;31:971-7. [ Links ]
29. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:1184-90. [ Links ]
30. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization and prognosis. Kidney Int 2005;68:293-301. [ Links ]
31. Kuroda S, Nishida N, Uzu T, Takeji M, Nishimura M, Fujii T, et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 2000;31:61-5. [ Links ]
32. Alcázar JM, Marín R, Gómez-Campderá F, Orte L, Rodríguez-Jornet A, Mora-Macía J; Spanish Group of Ischaemic Nephrology (GEDENI). Clinical characteristics of ischaemic renal disease. Nephrol Dial Transplant 2001;16:74-7. [ Links ]
33. Hans SS, Zeskind HJ. Routine use of limited abdominal aortography with digital subtraction carotid and cerebral angiography. Stroke 1995;26:1221-4. [ Links ]
34. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med 1994;96:10-4. [ Links ]
35. Wachtell K, Ibsen H, Olsen MH, Laybourn C, Christoffersen JK, Nørgaard HH, et al. Occurrence of renal artery stenosis in patients with peripheral arteriosclerosis and hypertension. Ugeskr Laeger 1997;159:6822-4. [ Links ]
36. Choudhri AH, Cleland JG, Rowlands PC, Tran TL, McCarty M, al-Kutoubi MA. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990;301:1197-8. [ Links ]
37. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18:185-92. [ Links ]
38. Jokhi PP, Ramanathan K, Walsh S, Fung AY, Saw J, Fox RS, et al. Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications. Can J Cardiol 2009;25:e273-8. [ Links ]
39. Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis. Eur Heart J 2002;23:1684-91. [ Links ]
40. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992;2:1608-16. [ Links ]
41. Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 1994;32:8-10. [ Links ]
42. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005;112:1362-74. [ Links ]
43. Kaplan NM, Flynn JT. Renovascular Hypertension. In: Clinical Hypertension, 9ª Ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 348. [ Links ]
44. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001;60:1490-7. [ Links ]
Correspondence to: Submitted on: 10/12/2011 FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Dr. Vilmar de Paiva Marques
Universidade Federal do Triângulo Mineiro
Rua Ricardo Misson, nº 369, apto. 301, Fabrício
Uberaba, MG, Brazil. CEP: 38065-200
Approved on: 04/30/2012
Submitted on: 10/12/2011
FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais.